ENGN – engene holdings inc. (US:NASDAQ)
Stock Stats
News
enGene Holdings Inc. (NASDAQ: ENGN) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $7.00 price target on the stock, down previously from $34.00.
enGene to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
enGene to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
enGene to Present Three Posters at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) Highlighting the Ongoing Clinical Development of Detalimogene Voraplasmid for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC) [Yahoo! Finance]
Form SCHEDULE 13G/A enGene Holdings Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
Form SCHEDULE 13G enGene Holdings Inc. Filed by: Kynam Capital Management, LP
Form SCHEDULE 13G/A enGene Holdings Inc. Filed by: Foresite Capital Fund VI LP
Form SCHEDULE 13G/A enGene Holdings Inc. Filed by: Deep Track Capital, LP
Form SCHEDULE 13G/A enGene Holdings Inc. Filed by: Adage Capital Management, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.